Trial intelligence / Profile preview

Phase II study of SHR-1701 combined with chemoradiotherapy as perioperative treatment for resectable locally advanced rectal cancer

CTR20220653Phase 2Active

Sponsor

Suzhou Shengdiya Biopharmaceuticals

Start

Jul 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1